menu search

OTLC / Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference
AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a leading developer of TGF-β therapeutics for oncology and virology, today announced that Dr. Vuong Trieu, Oncotelic Chairman and CEO, will be presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference (the “Conference”), from March 28 - April 1, 2022. Read More
Posted: Feb 24 2022, 08:47
Author Name: GlobeNewsWire
Views: 111860

OTLC News  

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

By GlobeNewsWire
February 24, 2022

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l more_horizontal

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

By GlobeNewsWire
February 24, 2022

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l more_horizontal

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

By GlobeNewsWire
February 24, 2022

Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l more_horizontal


Search within

Pages Search Results: